Literature DB >> 20610196

Pediatric oncology.

Andrew M Davidoff1.   

Abstract

Cancer is a disease whose progression is driven by a series of accumulating genetic and epigenetic changes influenced by hereditary factors and the somatic environment. These changes result in individual cells acquiring a phenotype that provides those cells with a survival advantage over surrounding normal cells. Our understanding of the processes that occur in malignant transformation is increasing, with many discoveries in cancer cell biology having been made through the study of childhood tumors. The processes involved in oncogenesis and cancer progression will be discussed in this review. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20610196      PMCID: PMC2914477          DOI: 10.1053/j.sempedsurg.2010.03.007

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  42 in total

1.  Molecular biology. Glimpses of a tiny RNA world.

Authors:  G Ruvkun
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

2.  Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN.

Authors:  T Teitz; T Wei; M B Valentine; E F Vanin; J Grenet; V A Valentine; F G Behm; A T Look; J M Lahti; V J Kidd
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

3.  PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group.

Authors:  Poul H B Sorensen; James C Lynch; Stephen J Qualman; Roberto Tirabosco; Jerian F Lim; Harold M Maurer; Julia A Bridge; William M Crist; Timothy J Triche; Frederic G Barr
Journal:  J Clin Oncol       Date:  2002-06-01       Impact factor: 44.544

4.  Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer.

Authors:  S Fulda; M U Küfer; E Meyer; F van Valen; B Dockhorn-Dworniczak; K M Debatin
Journal:  Oncogene       Date:  2001-09-13       Impact factor: 9.867

5.  Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma.

Authors:  A T Look; F A Hayes; R Nitschke; N B McWilliams; A A Green
Journal:  N Engl J Med       Date:  1984-07-26       Impact factor: 91.245

6.  Chromosomal aberrations in human neuroblastomas.

Authors:  G M Brodeur; G Sekhon; M N Goldstein
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

Review 7.  Genetic predisposition to cancer and familial cancer syndromes.

Authors:  S Quesnel; D Malkin
Journal:  Pediatr Clin North Am       Date:  1997-08       Impact factor: 3.278

8.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

Authors:  R C Seeger; G M Brodeur; H Sather; A Dalton; S E Siegel; K Y Wong; D Hammond
Journal:  N Engl J Med       Date:  1985-10-31       Impact factor: 91.245

9.  Transposition and amplification of oncogene-related sequences in human neuroblastomas.

Authors:  N E Kohl; N Kanda; R R Schreck; G Bruns; S A Latt; F Gilbert; F W Alt
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

10.  Cancer incidence, survival, and mortality for children younger than age 15 years.

Authors:  J L Young; L G Ries; E Silverberg; J W Horm; R W Miller
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

View more
  14 in total

Review 1.  Neonatal tumours.

Authors:  S W Moore
Journal:  Pediatr Surg Int       Date:  2013-10-31       Impact factor: 1.827

2.  Animal models of extracranial pediatric solid tumors.

Authors:  Guido Seitz; Sorin Armeanu-Ebinger; Steven Warmann; Jörg Fuchs
Journal:  Oncol Lett       Date:  2012-08-06       Impact factor: 2.967

3.  Applications of Artificial Intelligence in Pediatric Oncology: A Systematic Review.

Authors:  Siddhi Ramesh; Sukarn Chokkara; Timothy Shen; Ajay Major; Samuel L Volchenboum; Anoop Mayampurath; Mark A Applebaum
Journal:  JCO Clin Cancer Inform       Date:  2021-12

4.  A Scoping Review of Physical Therapy Interventions for Childhood Cancers.

Authors:  Paula A Ospina; Margaret L McNeely
Journal:  Physiother Can       Date:  2019       Impact factor: 1.037

5.  The critically-ill pediatric hemato-oncology patient: epidemiology, management, and strategy of transfer to the pediatric intensive care unit.

Authors:  Pierre Demaret; Geraldine Pettersen; Philippe Hubert; Pierre Teira; Guillaume Emeriaud
Journal:  Ann Intensive Care       Date:  2012-06-12       Impact factor: 6.925

6.  Epidemiology of childhood cancer.

Authors:  Benedetto Terracini
Journal:  Environ Health       Date:  2011-04-05       Impact factor: 5.984

7.  Autoantibody signature differentiates Wilms tumor patients from neuroblastoma patients.

Authors:  Jana Schmitt; Andreas Keller; Nasenien Nourkami-Tutdibi; Sabrina Heisel; Nunja Habel; Petra Leidinger; Nicole Ludwig; Manfred Gessler; Norbert Graf; Frank Berthold; Hans-Peter Lenhof; Eckart Meese
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

8.  A germline missense mutation in COQ6 is associated with susceptibility to familial schwannomatosis.

Authors:  Keqiang Zhang; Jia-Wei Lin; Jinhui Wang; Xiwei Wu; Hanlin Gao; Yi-Chen Hsieh; Peter Hwu; Yun-Ru Liu; Leila Su; Hung-Yi Chiou; Daidong Wang; Yate-Ching Yuan; Jacqueline Whang-Peng; Wen-Ta Chiu; Yun Yen
Journal:  Genet Med       Date:  2014-04-24       Impact factor: 8.822

9.  Prolonged non-survival in PICU: does a do-not-attempt-resuscitation order matter.

Authors:  Kam Lun E Hon; Terence Chuen Wai Poon; William Wong; Kin Kit Law; Hiu Wing Mok; Ka Wing Tam; Wai Kin Wong; Hiu Fung Wu; Ka Fai To; Kam Lau Cheung; Hon Ming Cheung; Ting Fan Leung; Chi Kong Li; Alexander K C Leung
Journal:  BMC Anesthesiol       Date:  2013-11-17       Impact factor: 2.217

Review 10.  Immunotherapeutic Challenges for Pediatric Cancers.

Authors:  Brian Hutzen; Mohammed Ghonime; Joel Lee; Elaine R Mardis; Ruoning Wang; Dean A Lee; Mitchell S Cairo; Ryan D Roberts; Timothy P Cripe; Kevin A Cassady
Journal:  Mol Ther Oncolytics       Date:  2019-08-28       Impact factor: 7.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.